RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $48,000 | -69.8% | 42,587 | -20.0% | 0.00% | -66.7% |
| Q1 2022 | $159,000 | +5.3% | 53,235 | -6.3% | 0.00% | 0.0% |
| Q4 2021 | $151,000 | -32.3% | 56,795 | -7.5% | 0.00% | -25.0% |
| Q3 2021 | $223,000 | -80.4% | 61,389 | -76.6% | 0.00% | -80.0% |
| Q2 2021 | $1,137,000 | +416.8% | 261,961 | +307.9% | 0.02% | +400.0% |
| Q1 2021 | $220,000 | -3.9% | 64,219 | -1.7% | 0.00% | -20.0% |
| Q4 2020 | $229,000 | +45.9% | 65,356 | -0.2% | 0.01% | +25.0% |
| Q3 2020 | $157,000 | +28.7% | 65,466 | -1.7% | 0.00% | +33.3% |
| Q2 2020 | $122,000 | +19.6% | 66,618 | +1.5% | 0.00% | 0.0% |
| Q1 2020 | $102,000 | -28.2% | 65,618 | -1.1% | 0.00% | -25.0% |
| Q4 2019 | $142,000 | +11.8% | 66,323 | -2.5% | 0.00% | +33.3% |
| Q3 2019 | $127,000 | -33.2% | 68,055 | -6.4% | 0.00% | -40.0% |
| Q2 2019 | $190,000 | -1.0% | 72,700 | -2.7% | 0.01% | 0.0% |
| Q1 2019 | $192,000 | +8.5% | 74,748 | -3.0% | 0.01% | -16.7% |
| Q4 2018 | $177,000 | -28.3% | 77,051 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $247,000 | +17.6% | 77,051 | +3.7% | 0.01% | 0.0% |
| Q2 2018 | $210,000 | -24.2% | 74,297 | -4.9% | 0.01% | -14.3% |
| Q1 2018 | $277,000 | -10.9% | 78,135 | -2.6% | 0.01% | -12.5% |
| Q4 2017 | $311,000 | +52.5% | 80,210 | -0.0% | 0.01% | +60.0% |
| Q3 2017 | $204,000 | -9.3% | 80,226 | -2.4% | 0.01% | -16.7% |
| Q2 2017 | $225,000 | -17.3% | 82,237 | -0.1% | 0.01% | -25.0% |
| Q1 2017 | $272,000 | +38.1% | 82,297 | -0.6% | 0.01% | +33.3% |
| Q4 2016 | $197,000 | -35.4% | 82,756 | -0.4% | 0.01% | -33.3% |
| Q3 2016 | $305,000 | +58.0% | 83,085 | -4.2% | 0.01% | +50.0% |
| Q2 2016 | $193,000 | 0.0% | 86,759 | -6.5% | 0.01% | 0.0% |
| Q1 2016 | $193,000 | -31.1% | 92,774 | +0.5% | 0.01% | -25.0% |
| Q4 2015 | $280,000 | +17.2% | 92,350 | -4.5% | 0.01% | +14.3% |
| Q3 2015 | $239,000 | -23.2% | 96,728 | -0.1% | 0.01% | -22.2% |
| Q2 2015 | $311,000 | -7.2% | 96,813 | +3.1% | 0.01% | 0.0% |
| Q1 2015 | $335,000 | +365.3% | 93,917 | +369.6% | 0.01% | +200.0% |
| Q3 2013 | $72,000 | +4.3% | 20,000 | -3.4% | 0.00% | 0.0% |
| Q2 2013 | $69,000 | – | 20,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |